Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial

Autor: Huttner, Angela, Hatz, Christoph, van den Dobbelsteen, Germie, Abbanat, Darren, Hornacek, Alena, Frölich, Rahel, Dreyer, Anita M, Martin, Patricia, Davies, Todd, Fae, Kellen, van den Nieuwenhof, Ingrid, Thoelen, Stefan, de Vallière, Serge, Kuhn, Anette, Bernasconi, Enos, Viereck, Volker, Kavvadias, Tilemachos, Kling, Kerstin, Ryu, Gloria, Hülder, Tanja, Gröger, Sabine, Scheiner, David, Alaimo, Cristina, Harbarth, Stephan, Poolman, Jan, Fonck, Veronica Gambillara
Zdroj: In The Lancet Infectious Diseases May 2017 17(5):528-537
Databáze: ScienceDirect